Campbell & CO Investment Adviser LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1353570 BALTIMORE, MD

Position in GILD

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,246,451

-$4,800,096 QoQ

Shares Held

17,781

-64.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#798

of 2,266 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $29,426,907 across 9 Drug Manufacturers - General names. GILD ranks #6 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	18,379	$6,655,403
2	AZN	Astrazeneca PLC	29,025	$5,503,720
3	LLY	ELI LILLY & Co	3,682	$4,416,301
4	GSK	GSK plc	83,989	$4,402,703
5	SNY	Sanofi	52,949	$2,258,804
6	GILD	Gilead Sciences, Inc. This page	17,781	$2,246,451
7	PFE	Pfizer Inc	75,099	$1,808,383
8	BMY	Bristol Myers Squibb Co	23,327	$1,344,101

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,246,451	17,781	-64.8%	Shares	Sole	2026-08-03
2026-03-31	$7,046,547	50,560	+343.1%	Shares	Sole	2026-05-15
2025-12-31	$1,400,586	11,411	-9.5%	Shares	Sole	2026-02-12
2025-09-30	$1,398,822	12,602	-56.3%	Shares	Sole	2025-10-28
2025-03-31	$3,228,160	28,810	+531.1%	Shares	Sole	2025-05-14
2024-03-31	$334,386	4,565	-38.6%	Shares	Sole	2024-05-10
2023-12-31	$602,390	7,436	+19.1%	Shares	Sole	2024-02-13
2023-09-30	$467,700	6,241	-18.9%	Shares	Sole	2023-11-08
2023-03-31	$638,869	7,700	-68.9%	Shares	Sole	2023-05-11
2020-09-30	$1,566,480	24,790	—	Shares	Sole	2020-10-15
No filing history on record for this holder in this stock.